Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kramer

Showing results (141-150 of 240) with videos related to

Pageof 24
Sort By:
Cancer Research|October 19, 2018
JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-LetterMalte von Bonin, Katharina Moll, Michael Kramer, et al.
Haematologica|November 27, 2014
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoringUta Oelschlaegel, Theresia M Westers, Brigitte Mohr, et al.
Annals of Epidemiology|July 10, 2018
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United StatesAaron J Siegler, Farah Mouhanna, Robertino Mera Giler, et al.
Oncotarget|September 15, 2017
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpressionTheresa Link, Friederike Kuithan, Armin Ehninger, et al.
Annals of Epidemiology|July 25, 2018
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017Patrick S Sullivan, Robertino Mera Giler, Farah Mouhanna, et al.
Clinical Colorectal Cancer|November 13, 2021
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)Gunnar Folprecht, Anke Reinacher-Schick, Jürgen Weitz, et al.
Nature Astronomy|May 27, 2024
A freely precessing magnetar following an X-ray outburstGregory Desvignes, Patrick Weltevrede, Yong Gao, et al.
American Journal of Obstetrics and Gynecology|April 4, 2006
Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?José Villar, Guillermo Carroli, Daniel Wojdyla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 8, 2023
Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular EndplatesFlorian Ingelfinger, Michael Kramer, Mirjam Lutz, et al.
BMC Medical Research Methodology|January 13, 2026
Improving the design of epidemiology studies that use biomonitoring for exposure assessment: a SciPinion panel recommendationIgor Burstyn, Louis Anthony Cox, Yang Cao, et al.
Pageof 24

Showing results (141-150 of 240) with videos related to

Sort By:
Pageof 24
Cancer Research|October 19, 2018
JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-LetterMalte von Bonin, Katharina Moll, Michael Kramer, et al.
Haematologica|November 27, 2014
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoringUta Oelschlaegel, Theresia M Westers, Brigitte Mohr, et al.
Annals of Epidemiology|July 10, 2018
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United StatesAaron J Siegler, Farah Mouhanna, Robertino Mera Giler, et al.
Oncotarget|September 15, 2017
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpressionTheresa Link, Friederike Kuithan, Armin Ehninger, et al.
Annals of Epidemiology|July 25, 2018
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017Patrick S Sullivan, Robertino Mera Giler, Farah Mouhanna, et al.
Clinical Colorectal Cancer|November 13, 2021
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)Gunnar Folprecht, Anke Reinacher-Schick, Jürgen Weitz, et al.
Nature Astronomy|May 27, 2024
A freely precessing magnetar following an X-ray outburstGregory Desvignes, Patrick Weltevrede, Yong Gao, et al.
American Journal of Obstetrics and Gynecology|April 4, 2006
Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?José Villar, Guillermo Carroli, Daniel Wojdyla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 8, 2023
Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular EndplatesFlorian Ingelfinger, Michael Kramer, Mirjam Lutz, et al.
BMC Medical Research Methodology|January 13, 2026
Improving the design of epidemiology studies that use biomonitoring for exposure assessment: a SciPinion panel recommendationIgor Burstyn, Louis Anthony Cox, Yang Cao, et al.
Pageof 24